These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 2580616)

  • 1. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
    Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.
    Wassermann K; Zwelling LA; Lown JW; Hartley JA; Nishikawa K; Lin JR; Newman RA
    Cancer Res; 1990 Mar; 50(6):1732-7. PubMed ID: 1689610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma.
    Zuckerman JE; Raffin TA; Brown JM; Newman RA; Etiz BB; Sikic BI
    Cancer Res; 1986 Apr; 46(4 Pt 1):1748-53. PubMed ID: 2418953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists.
    Lazo JS; Hait WN; Kennedy KA; Braun ID; Meandzija B
    Mol Pharmacol; 1985 Mar; 27(3):387-93. PubMed ID: 2579318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial single-strand DNA damage and cellular pharmacokinetics of bleomycin A2.
    Lazo JS; Schisselbauer JC; Meandzija B; Kennedy KA
    Biochem Pharmacol; 1989 Jul; 38(13):2207-13. PubMed ID: 2472141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from adriamycin cytotoxicity in L1210 cells by brefeldin A.
    Vichi PJ; Tritton TR
    Cancer Res; 1993 Nov; 53(21):5237-43. PubMed ID: 8106144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of bleomycin cytotoxicity by polyhydric alcohols.
    Suzuki T; Kohda K; Kawazoe Y
    Anticancer Res; 1990; 10(1):97-103. PubMed ID: 1692198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1984 Aug; 44(8):3360-5. PubMed ID: 6744270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
    Bowman KJ; Newell DR; Calvert AH; Curtin NJ
    Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damage and repair induced by bleomycin in the domain of human amplified MYC oncogenes.
    Bianchi NO; Bianchi MS; López-Larraza D; Alitalo K; de la Chapelle A
    Cancer Res; 1990 Apr; 50(8):2379-84. PubMed ID: 1690597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of erythrocytes on alveolar macrophage cytostatic activity induced by bleomycin lung damage in rats.
    Huot AE; Gundel RM; Hacker MP
    Cancer Res; 1990 Apr; 50(8):2351-5. PubMed ID: 1690596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
    Epstein RJ; Smith PJ
    Cancer Res; 1988 Jan; 48(2):297-303. PubMed ID: 2825970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cytotoxicity caused by increased DNA strand breakage resulting from synergistic potentiation of bleomycin with Bacillus thuringiensis subsp. israelensis delta-endotoxin.
    Yokoyama Y; Kohda K
    Anticancer Res; 1994; 14(3A):837-40. PubMed ID: 7521154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of hyperthermia with bleomycin and liblomycin: effects on CHO cells in vitro.
    Dogramatzis D; Nishikawa K; Newman RA
    Anticancer Res; 1991; 11(3):1359-64. PubMed ID: 1716087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of etoposide cytotoxicity and DNA strand scission in L1210 and 8226 cells by polyamines.
    Dorr RT; Liddil JD; Gerner EW
    Cancer Res; 1986 Aug; 46(8):3891-5. PubMed ID: 3015379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modulation of bleomycin induced toxicity.
    Kennedy KA; Hait WN; Lazo JS
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1367-70. PubMed ID: 2428791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the cellular vacuolar system with the cytotoxicity of bleomycin-like agents.
    Lazo JS; Schisselbauer JC; Herring GM; Kennedy KA
    Cancer Commun; 1990; 2(2):81-6. PubMed ID: 1695520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.